BIORASI, LLC
AVENTURA, FLORIDA

Founded in 2002 by Boris N. Reznik, BIORASI, LLC stands out as a Clinical Research Organization (CRO) that focuses on improving clinical trials for pharmaceutical and biotechnology clients. From its inception, the company aimed to hasten the delivery of safe and effective therapies to market. Achieving this goal hinges on leveraging technology, astute management, and adept project teams. BIORASI’s headquarters are nestled in Aventura, Florida, but it has an expansive presence with offices across key global regulatory regions. This strategic positioning allows them to maintain the personalized attention of a boutique CRO while operating at the scale of major players in this space. Their experience in diverse regulatory environments gives them an edge when handling complex trial demands worldwide. Central to their success is Biorasi's Clinical Research Optimized™ approach, which integrates its proprietary TALOS™ technology, comprehensive staff training, and a unique company culture rooted in employee ownership. These components are designed to quicken trial completion times and increase the odds of achieving drug approvals. Among the industry, BIORASI has gained notoriety as an adept problem-solver for trials encountering issues that might overwhelm larger CROs. This skill is crucial as BIORASI plays a pivotal role in saving both time and costs while safeguarding at-risk drug development initiatives. The company is guided by a board of experienced professionals, including Dr. Kurt Ghelsen in oncology, Dr. Russel Kaufman with investment insights, and Doug Klinger's entrepreneurial acumen in healthcare. Operating under incorporation number L02000034035 and headquartered at 19505 Biscayne Blvd., Aventura, FL, BIORASI was established on December 18, 2002. They continue to uphold their active status in the industry with regular updates, such as filing their latest annual report by April 19, 2024.